Related Experiment Videos
[Risk factors for cutaneous wart onset in transplant recipients]
C Pruvost1, D Penso-Assathiany, N Bachot
1Service de Dermatologie, Hôpital Henri Mondor, 51, avenue Maréchal de Lattre de Tassigny, 94010 Créteil.
Annales De Dermatologie Et De Venereologie
|May 4, 2002
Summary
The prevalence of cutaneous warts increases with transplant duration and immunosuppressive therapy intensity. Transplant recipients with fewer warts received less intensive immunosuppression, indicating a key risk factor.
Area of Science:
- Dermatology
- Transplantation Immunology
- Epidemiology
Context:
- Transplant recipients face a higher risk of developing cutaneous warts.
- Understanding the onset and risk factors for warts is crucial for patient management.
Purpose:
- To investigate the delay in onset of cutaneous warts in transplant recipients.
- To identify potential risk factors associated with wart development post-transplant.
Summary:
- Wart prevalence increases with immunosuppression duration, reaching 54% by 7 years post-transplant.
- Warts are typically multiple, located on hands, and have a chronic course.
- Less intensive immunosuppressive therapy correlated with a lower incidence of warts at 3 years.
Impact:
- Highlights the significant impact of immunosuppression intensity on wart development.
- Provides evidence for managing immunosuppressive therapy to potentially reduce wart occurrence.
- Informs clinical practice regarding surveillance and management of skin conditions in transplant patients.